As the equine industry continues to advance toward greater professionalism and scientific management, health monitoring has become an essential part of performance training, breeding programs, and daily horse care. The ability to obtain fast and accurate health data is now more important than ever.
Founded in 1999 and headquartered in Taiwan, China, General Life Biotechnology Co., Ltd. has been dedicated to the research, development, and manufacturing of innovative medical diagnostic devices. In 2015, the company became part of the Compal Group, further strengthening its global presence and R&D capabilities.
With its two well-established brands, BeneCheck and SANcheck, the company specializes in point-of-care diagnostic solutions for both human and veterinary applications. Guided by the core values of Precision, Reliability, and Innovation, General Life Biotechnology continuously develops advanced diagnostic technologies to support better health management for both people and animals.
For the equine industry, the company introduces the StrideVet 4-in-1 Equine Testing System (BC0160-V), providing veterinarians, trainers, and horse owners with rapid, on-site diagnostic support. Combining the latest veterinary research with clinical expertise, the system delivers reliable results within seconds using only a tiny blood sample.

Blood Glucose
* Sample volume: 0.7 μL
* Test time: 5 seconds
* Used together with triglyceride testing to evaluate energy metabolism and insulin function.
Lactate
* Sample volume: 0.7 μL
* Test time: 15 seconds
* Assists in assessing exercise fatigue, tissue hypoxia, Systemic Inflammatory Response Syndrome (SIRS), and sepsis risk.
Hematocrit (HCT/PCV)
* Sample volume: 1.0 μL
* Test time: 6 seconds
* A key indicator for dehydration, anemia, blood loss, and oxygenation status in neonatal foals.
Triglycerides (TG)
* Sample volume: 1.0 μL
* Test time: 60 seconds
* An important clinical marker for evaluating insulin resistance and diagnosing Equine Metabolic Syndrome (EMS).
The StrideVet system also provides valuable support for breeding operations and foal management. By monitoring hematocrit and metabolic indicators, veterinarians can better assess the health of broodmares during the perinatal period as well as the overall condition of newborn foals. For young horses, it serves as a practical tool for monitoring metabolic health and growth.
Unlike conventional laboratory testing, portable point-of-care diagnostics enable immediate health assessments directly in the field. Whether at competitions, equestrian clubs, stables, or breeding farms, the system offers flexible and efficient testing to support smarter, more precise equine healthcare.
From performance monitoring and disease screening to breeding management and routine wellness evaluation, the StrideVet 4-in-1 Equine Testing System is helping advance modern equine healthcare with faster and more reliable diagnostic solutions.

Driven by science and inspired by innovation, General Life Biotechnology looks forward to welcoming industry professionals to its booth at CHF Shenzhen 2026.
16–18 September 2026
Shenzhen World Exhibition & Convention Center (Bao’an), Shenzhen, China
Booth: 12G46
Contact Person: Sophiay Yang
WeChat: lom517
Email: sophiayang@horsefair.com.cn